focal acral hyperkeratosis
ORPHA: 3080132 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| salicylic acid | topical solution 17%; gel 6%; cream 3%, 6%; plaster | FDA Approved | 8 | 3d |
| urea | topical cream 10%, 20%, 40%; lotion; ointment | FDA Approved | 7 | 5d |
Classification & Codes
Orphanet Code
ORPHA:308013focal acral hyperkeratosis
| Orphanet | ORPHA:308013 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO